Contrast Agent Lowers Side Effects

 

November 15, 2007

Guerbet will feature its Oxilan (ioxilan) injection, a contrast agent that is a nonionic low-viscous and low-osmolar monomer at RSNA 2007.

Although opacification is a major metric used to judge the quality of contrast media, other significant characteristics such as ionicity, chemical structure, osmolality and viscosity have important influences on their efficacy and safety. Guerbet has emphasized the point that these additional characteristics can significantly effect visualization, hemodynamics, thrombogenecity, contrast-induced nephropathy and other various clinical outcomes. This emphasis has been implemented in the development of Oxilan, whose chemical characteristics have resulted in high quality imaging with minimal side effects, according to the manufacturer.

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.